UNIGE document Scientific Article
previous document  unige:26015  next document
add to browser collection
Title

Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia: results of the GRAAPH-2003 study

Authors
de Labarthe, Adrienne
Rousselot, Philippe
Huguet-Rigal, Françoise
Delabesse, Eric
Witz, Francis
Maury, Sébastien
Réa, Delphine
Cayuela, Jean-Michel
show hidden authors show all authors [1 - 20]
Published in Blood. 2007, vol. 109, no. 4, p. 1408-13
Abstract The combination of imatinib with chemotherapy has been recently reported as very promising in patients with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL). During 2004 and 2005, 45 patients with newly diagnosed Ph+ ALL were treated in the Group for Research on Adult Acute Lymphoblastic Leukemia (GRAAPH) 2003 study, in which imatinib was started with HAM (mitoxantrone with intermediate-dose cytarabine) consolidation in good early responders (corticosensitive and chemosensitive ALL) or earlier during the induction course in combination with dexamethasone and vincristine in poor early responders (corticoresistant and/or chemoresistant ALL). Imatinib was then continuously administered until stem cell transplantation (SCT). Overall, complete remission (CR) and BCR-ABL real-time quantitative polymerase chain reaction (RQ-PCR) negativity rates were 96% and 29%, respectively. All of the 22 CR patients (100%) with a donor actually received allogeneic SCT in first CR. At 18 months, the estimated cumulative incidence of relapse, disease-free survival, and overall survival were 30%, 51%, and 65%, respectively. These 3 end points compared very favorably with results obtained in the pre-imatinib LALA-94 trial. This study confirms the value of the combined approach and encourages prospective trials to define the optimal chemotherapy that has to be combined with imatinib and to carefully reevaluate the place of allogeneic SCT in this new context.
Keywords AdolescentAdultAntineoplastic Combined Chemotherapy Protocols/therapeutic useCytarabine/therapeutic useFemaleHematopoietic Stem Cell TransplantationHumansMaleMiddle AgedMitoxantrone/therapeutic useNeoplasmResidualPhiladelphia ChromosomePiperazines/administration & dosagePrecursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy/mortalityPyrimidines/administration & dosageRemission InductionSurvival AnalysisTransplantationHomologous
Identifiers
PMID: 17062730
Full text
Article (Published version) (277 Kb) - private document Private access
Structures
Citation
(ISO format)
DE LABARTHE, Adrienne et al. Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia: results of the GRAAPH-2003 study. In: Blood, 2007, vol. 109, n° 4, p. 1408-13. https://archive-ouverte.unige.ch/unige:26015

179 hits

0 download

Update

Deposited on : 2013-01-29

Export document
Format :
Citation style :